• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶原屏障中喹诺酮类药物治疗耐氨基糖苷类铜绿假单胞菌性角膜炎

Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.

作者信息

Hobden J A, Reidy J J, O'Callaghan R J, Insler M S, Hill J M

机构信息

Department of Microbiology, Louisiana State University Medical Center School of Medicine, New Orleans.

出版信息

Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2241-3.

PMID:2173684
Abstract

Rabbit corneas were infected with a tobramycin-resistant (minimum inhibitory concentration, 31.25 micrograms/ml) strain of Pseudomonas aeruginosa 27853 (10(3) colony-forming units) and were treated 22 hours later with collagen corneal shields hydrated in either 25 mg/ml ciprofloxacin, 40 mg/ml norfloxacin, 40 mg/ml tobramycin, or deionized water. Shields were removed at 26 hours postinfection, and 1 hour later, corneas were harvested for bacterial enumeration. Application of shields hydrated in ciprofloxacin reduced the number of viable bacteria per cornea approximately 4 log units compared with the application of shields containing tobramycin or deionized water (P less than 0.0001). Use of shields hydrated in norfloxacin reduced the number of P. aeruginosa organisms by greater than 2 log units compared with shields containing tobramycin or deionized water (P less than 0.0001). Ciprofloxacin was significantly more effective than norfloxacin in reducing the number of bacteria per cornea (P less than 0.0001). There was no significant difference in the number of bacteria recovered from corneas treated with tobramycin or deionized water (P less than 0.56).

摘要

用对妥布霉素耐药(最低抑菌浓度为31.25微克/毫升)的铜绿假单胞菌27853菌株(10³ 菌落形成单位)感染兔角膜,22小时后用在25毫克/毫升环丙沙星、40毫克/毫升诺氟沙星、40毫克/毫升妥布霉素或去离子水中水化的胶原角膜罩进行治疗。在感染后26小时移除角膜罩,1小时后,采集角膜进行细菌计数。与使用含妥布霉素或去离子水的角膜罩相比,使用在环丙沙星中水化的角膜罩可使每个角膜的活菌数减少约4个对数单位(P<0.0001)。与使用含妥布霉素或去离子水的角膜罩相比,使用在诺氟沙星中水化的角膜罩可使铜绿假单胞菌数量减少超过2个对数单位(P<0.0001)。在减少每个角膜细菌数量方面,环丙沙星比诺氟沙星显著更有效(P<0.0001)。用妥布霉素或去离子水处理的角膜回收的细菌数量没有显著差异(P<0.56)。

相似文献

1
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.胶原屏障中喹诺酮类药物治疗耐氨基糖苷类铜绿假单胞菌性角膜炎
Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2241-3.
2
The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.局部应用环丙沙星和诺氟沙星治疗实验性铜绿假单胞菌角膜炎的疗效。
Cornea. 1991 Jan;10(1):25-8.
3
Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.铜绿假单胞菌性角膜炎的角膜切开术模型:庆大霉素化疗
Refract Corneal Surg. 1992 Jan-Feb;8(1):39-43.
4
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.环丙沙星与妥布霉素治疗葡萄球菌性角膜炎的对比研究
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1033-7.
5
Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.环丙沙星离子导入治疗耐氨基糖苷类铜绿假单胞菌角膜炎
Invest Ophthalmol Vis Sci. 1990 Oct;31(10):1940-4.
6
A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.环丙沙星耐药铜绿假单胞菌抗生素治疗的实验室评估
Am J Ophthalmol. 2004 Aug;138(2):226-30. doi: 10.1016/j.ajo.2004.03.016.
7
Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.非诺-D-精氨酸治疗铜绿假单胞菌角膜炎
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):256-62. doi: 10.1167/iovs.08-2344. Epub 2008 Sep 4.
8
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.在葡萄球菌性和铜绿假单胞菌性角膜炎兔模型中,局部应用洗必泰、环丙沙星以及强化妥布霉素/头孢唑林的比较。
J Ocul Pharmacol Ther. 2007 Jun;23(3):213-20. doi: 10.1089/jop.2006.81.
9
Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.溶葡萄球菌素治疗兔耐甲氧西林金黄色葡萄球菌性角膜炎
Invest Ophthalmol Vis Sci. 2000 May;41(6):1432-7.
10
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.在兔金黄色葡萄球菌角膜炎模型中,局部应用牛磺罗定与环丙沙星、氧氟沙星和强化头孢唑林的疗效比较。
Curr Eye Res. 2005 Mar;30(3):155-61. doi: 10.1080/02713680490908733.

引用本文的文献

1
Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.环丙沙星和其他氟喹诺酮类抗生素的眼部光毒性的检测和预防。
Photochem Photobiol. 2010 Jul-Aug;86(4):798-805. doi: 10.1111/j.1751-1097.2010.00755.x. Epub 2010 Jun 1.
2
Real-time visualization of photochemically induced fluorescence of 8-halogenated quinolones: lomefloxacin, clinafloxacin and Bay3118 in live human HaCaT keratinocytes.实时可视化 8-卤代喹诺酮类药物:洛美沙星、克林沙星和 Bay3118 在活的人 HaCaT 角质形成细胞中的光化学诱导荧光。
Photochem Photobiol. 2010 Jul-Aug;86(4):792-7. doi: 10.1111/j.1751-1097.2010.00741.x. Epub 2010 May 13.
3
Pharmacokinetic considerations in the treatment of bacterial keratitis.
细菌性角膜炎治疗中的药代动力学考量
Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005.